GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Current Deferred Revenue

Orion Pharma (DHA:ORIONPHARM) Current Deferred Revenue : BDT0 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Orion Pharma's current deferred revenue for the quarter that ended in Dec. 2023 was BDT0 Mil.

Orion Pharma Current Deferred Revenue Historical Data

The historical data trend for Orion Pharma's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Current Deferred Revenue Chart

Orion Pharma Annual Data
Trend Dec13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Orion Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Orion Pharma Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma (DHA:ORIONPHARM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Current Deferred Revenue
Comparable Companies
DHA:SPCL SHSE:600900 HKSE:01816 BOM:533096 SHSE:600011 VST LSE:CNA HKSE:00006 BOM:539254 NRG HKSE:00836 BOM:500400 SHSE:600674 SHSE:600023 NSE:JSWENERGY SHSE:601991 BUE:PAMP DFM:EMPOWER ASX:AGL BOM:532779
Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Website
https://www.orionpharmabd.com
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines